Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Olema Pharmaceuticals (OLMA) Non-cash Items (2020 - 2026)

Olema Pharmaceuticals (OLMA) has 7 years of Non-cash Items data on record, last reported at $91.9 million in Q1 2026.

  • On a quarterly basis, Non-cash Items rose 6861.44% to $91.9 million in Q1 2026 year-over-year; TTM through Mar 2026 was $91.9 million, a 6861.44% increase, with the full-year FY2025 number at $235.7 million, up 3034.19% from a year prior.
  • Non-cash Items reached $91.9 million in Q1 2026 per OLMA's latest filing, down from $235.7 million in the prior quarter.
  • Over the last five years, Non-cash Items for OLMA hit a ceiling of $235.7 million in Q4 2025 and a floor of $262000.0 in Q4 2022.
  • A 5-year average of $39.1 million and a median of $31.6 million in 2023 define the central range for Non-cash Items.
  • Peak YoY movement for Non-cash Items: crashed 99.51% in 2022, then skyrocketed 23468.32% in 2023.
  • Tracing OLMA's Non-cash Items over 5 years: stood at $262000.0 in 2022, then surged by 23468.32% to $61.7 million in 2023, then plummeted by 87.82% to $7.5 million in 2024, then soared by 3034.19% to $235.7 million in 2025, then tumbled by 61.01% to $91.9 million in 2026.
  • Business Quant data shows Non-cash Items for OLMA at $91.9 million in Q1 2026, $235.7 million in Q4 2025, and $52.0 million in Q3 2025.